Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950137-05-003911
Filing Date
2005-03-31
Accepted
2005-03-30 21:34:50
Documents
8
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c92089e10vk.htm 10-K 659138
2 OFFER LETTER DATED JUNE 1, 2004 c92089exv10w42.htm EX-10.42 5955
3 OFFER LETTER DATED NOVEMBER 15, 2004 c92089exv10w58.htm EX-10.58 4102
4 AMENDED AND RESTATED AKORN, INC. 2003 STOCK PLAN OPTION c92089exv10w59.htm EX-10.59 140994
5 CERTIFICATION OF CEO PURSUANT TO SECTION 302 c92089exv31w1.htm EX-31.1 4354
6 CERTIFICATION OF CFO PURSUANT TO SECTION 302 c92089exv31w2.htm EX-31.2 4358
7 CERTIFICATION OF CEO PURSUANT TO SECTION 906 c92089exv32w1.htm EX-32.1 2120
8 CERTIFICATION OF CFO PURSUANT TO SECTION 906 c92089exv32w2.htm EX-32.2 2176
  Complete submission text file 0000950137-05-003911.txt   825762
Mailing Address 100 TRI STATE INTERNATIONAL SUITE 100 LINCOLNSHIRE IL 60069
Business Address 2500 MILLBROOK DRIVE BUFFALO GROVE IL 60089 8472796100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32360 | Film No.: 05716170
SIC: 2834 Pharmaceutical Preparations